Skip to content

Clinical trials

Lipid Metabolism Disorders trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lipid Metabolism Disorders Country / region: Brazil Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20081
20121
20141
20151
20191
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kastle Therapeutics, LLC2
Alexion Pharmaceuticals, Inc.1
Federal University of Minas Gerais1
InCor Heart Institute1
Indústria Brasileira Equipamentos Médicos - IBRAMED1
Santa Catarina Federal University1
Shire1
Universidade Estadual de Londrina1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lipid Metabolism Disorders9
Metabolic Diseases5
Genetic Diseases, Inborn4
Metabolism, Inborn Errors4
Dyslipidemias3
Infant, Newborn, Diseases3
Lipid Metabolism, Inborn Errors3
Congenital Abnormalities2
Homozygous Familial Hypercholesterolemia2
Hypercholesterolemia2

Trials

Showing 51 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.